Lv3
380 积分 2023-09-03 加入
A multicenter, randomized, double-blinded, placebo-controlled phase III trial to evaluate efficacy and safety of picankibart in moderate-to-severe plaque psoriasis
4天前
已完结
Relationship between the pathogenesis of psoriasis and microbial flora
26天前
已关闭
Efficacy and safety of rocatinlimab for the treatment of moderate-to-severe atopic dermatitis in ROCKET-IGNITE and ROCKET-HORIZON: two global, double-blind, placebo-controlled, randomised phase 3 clinical trials
1个月前
已完结
Bifidobacterium longum mediated tryptophan metabolism to improve atopic dermatitis via the gut-skin axis
3个月前
已完结
The Role of the Gastrointestinal microbiome on Rheumatoid arthritis, Psoriatic arthritis, Ankylosing spondylitis and Reactive arthritis: A Systematic Review
3个月前
已完结
Differences in the gut Firmicutes to Bacteroidetes ratio across age groups in healthy Ukrainian population
3个月前
已完结
Longitudinal Interaction Between Individualized Gut Microbial Dynamics and Diet Is Associated with Metabolic Health in School-Aged Children
3个月前
已完结
Multi-omics joint analysis: Pachymic acid ameliorated non-alcoholic fatty liver disease by regulating gut microbiota
3个月前
已完结
Oral Icotrokinra for Plaque Psoriasis in Adults and Adolescents
5个月前
已完结
Once-daily oral icotrokinra versus placebo and once-daily oral deucravacitinib in participants with moderate-to-severe plaque psoriasis (ICONIC-ADVANCE 1 & 2): two phase 3, randomised, placebo-controlled and active-comparator-controlled trials
5个月前
已完结
皖公网安备34019202002308
